BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Özdemir R, Korkmaz HA, Küçük M, Karadeniz C, Meşe T, Özkan B. Assessment of early atherosclerosis and left ventricular dysfunction in children with 21-hydroxylase deficiency. Clin Endocrinol 2017;86:473-9. [DOI: 10.1111/cen.13275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Tuhan H, Demircan T, Altıncık A, Çatlı G, Kızılca Ö, Egeli T, Kır M, Can Ş, Dündar B, Böber E, Abacı A. Impaired systolic and diastolic left ventricular function in children and adolescents with congenital adrenal hyperplasia receiving corticosteroid therapy. Cardiol Young 2019;29:319-24. [PMID: 30675832 DOI: 10.1017/S1047951118002330] [Reference Citation Analysis]
2 Mooij CF, Pourier MS, Weijers G, de Korte CL, Fejzic Z, Claahsen-van der Grinten HL, Kapusta L. Cardiac function in paediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. Clin Endocrinol 2018;88:364-71. [DOI: 10.1111/cen.13529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature. Acta Biomed 2019;90:360-9. [PMID: 31580328 DOI: 10.23750/abm.v90i3.8732] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Gomes LG, Mendonca BB, Bachega TASS. Long-term cardio-metabolic outcomes in patients with classical congenital adrenal hyperplasia: is the risk real? Curr Opin Endocrinol Diabetes Obes 2020;27:155-61. [PMID: 32304389 DOI: 10.1097/MED.0000000000000545] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Borges JH, Santoro RI, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Guerra-Júnior G, Gonçalves EM. Cardiovascular dysfunction risk in young adults with congenital adrenal hyperplasia caused by 21-hydroxylase enzyme deficiency. Int J Clin Pract 2021;75:e14233. [PMID: 33884716 DOI: 10.1111/ijcp.14233] [Reference Citation Analysis]
6 White PC. Update on diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Curr Opin Endocrinol Diabetes Obes 2018;25:178-84. [PMID: 29718004 DOI: 10.1097/MED.0000000000000402] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
7 Yang M, Luo Y, Liu T, Zhong X, Yan J, Huang Q, Tao J, He Q, Guo M, Hu Y. The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: ARandomized Controlled Trial. Clin Ther 2018;40:1752-1764.e1. [PMID: 30245282 DOI: 10.1016/j.clinthera.2018.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Improda N, Barbieri F, Ciccarelli GP, Capalbo D, Salerno M. Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency. Front Endocrinol (Lausanne) 2019;10:212. [PMID: 31031703 DOI: 10.3389/fendo.2019.00212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Borges JH, de Oliveira DM, de Lemos-Marini SHV, Geloneze B, Gonçalves EM, Guerra-Júnior G. Fat Distribution and Lipid Profile of Young Adults with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Enzyme Deficiency. Lipids 2021;56:101-10. [PMID: 32929736 DOI: 10.1002/lipd.12280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]